273 related articles for article (PubMed ID: 27421971)
21. Pattern of 18F-FDG uptake in the spinal cord in patients with non-central nervous system malignancy.
Do BH; Mari C; Tseng JR; Quon A; Rosenberg J; Biswal S
Spine (Phila Pa 1976); 2011 Oct; 36(21):E1395-401. PubMed ID: 21311407
[TBL] [Abstract][Full Text] [Related]
22. Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: assessed with [(11)C]-PBR28.
Zürcher NR; Loggia ML; Lawson R; Chonde DB; Izquierdo-Garcia D; Yasek JE; Akeju O; Catana C; Rosen BR; Cudkowicz ME; Hooker JM; Atassi N
Neuroimage Clin; 2015; 7():409-14. PubMed ID: 25685708
[TBL] [Abstract][Full Text] [Related]
23. Striatal hypometabolism in premanifest and manifest Huntington's disease patients.
López-Mora DA; Camacho V; Pérez-Pérez J; Martínez-Horta S; Fernández A; Sampedro F; Montes A; Lozano-Martínez GA; Gómez-Anson B; Kulisevsky J; Carrió I
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2183-2189. PubMed ID: 27349245
[TBL] [Abstract][Full Text] [Related]
24.
Na SJ; Oh JK; Hyun SH; Lee JW; Hong IK; Song BI; Kim TS; Eo JS; Lee SW; Yoo IR; Chung YA; Yun M
J Nucl Med; 2017 May; 58(5):730-736. PubMed ID: 27789714
[TBL] [Abstract][Full Text] [Related]
25. Longitudinal evaluation of cerebral and spinal cord damage in Amyotrophic Lateral Sclerosis.
de Albuquerque M; Branco LM; Rezende TJ; de Andrade HM; Nucci A; França MC
Neuroimage Clin; 2017; 14():269-276. PubMed ID: 28203530
[TBL] [Abstract][Full Text] [Related]
26. Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis.
Pagani M; Chiò A; Valentini MC; Öberg J; Nobili F; Calvo A; Moglia C; Bertuzzo D; Morbelli S; De Carli F; Fania P; Cistaro A
Neurology; 2014 Sep; 83(12):1067-74. PubMed ID: 25122207
[TBL] [Abstract][Full Text] [Related]
27. Potential use of (18)F-FDG-PET/CT to visualize hypermetabolism associated with muscle pain in patients with adult spinal deformity: a case report.
Taniguchi Y; Takahashi M; Matsudaira K; Oka H; Momose T
Skeletal Radiol; 2016 Nov; 45(11):1577-81. PubMed ID: 27562570
[TBL] [Abstract][Full Text] [Related]
28. Preparation methods prior to PET/CT scanning that decrease uptake of 18F-FDG by myocardium, brown adipose tissue, and skeletal muscle.
Shao D; Tian XW; Gao Q; Liang CH; Wang SX
Acta Radiol; 2017 Jan; 58(1):10-18. PubMed ID: 26936898
[TBL] [Abstract][Full Text] [Related]
29. Methodologic Considerations for Quantitative 18F-FDG PET/CT Studies of Hepatic Glucose Metabolism in Healthy Subjects.
Trägårdh M; Møller N; Sørensen M
J Nucl Med; 2015 Sep; 56(9):1366-71. PubMed ID: 26159590
[TBL] [Abstract][Full Text] [Related]
30. Spinal Cord Gray Matter Atrophy in Amyotrophic Lateral Sclerosis.
Paquin MÊ; El Mendili MM; Gros C; Dupont SM; Cohen-Adad J; Pradat PF
AJNR Am J Neuroradiol; 2018 Jan; 39(1):184-192. PubMed ID: 29122760
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of total lesion glycolysis measured by 18F-FDG PET/CT in patients with locally advanced cervical cancer.
Hong JH; Jung US; Min KJ; Lee JK; Kim S; Eo JS
Nucl Med Commun; 2016 Aug; 37(8):843-8. PubMed ID: 27058362
[TBL] [Abstract][Full Text] [Related]
32. Analysis of metastatic involvement in bone using anatomical and functional information from 18F-FDG PET/CT.
Demirkaya O; AlQahtani M; Alsugair A; Aras O; Abouzied ME
Nucl Med Commun; 2017 Sep; 38(9):780-787. PubMed ID: 28704338
[TBL] [Abstract][Full Text] [Related]
33. Imaging of brain TSPO expression in a mouse model of amyotrophic lateral sclerosis with (18)F-DPA-714 and micro-PET/CT.
Gargiulo S; Anzilotti S; Coda AR; Gramanzini M; Greco A; Panico M; Vinciguerra A; Zannetti A; Vicidomini C; Dollé F; Pignataro G; Quarantelli M; Annunziato L; Brunetti A; Salvatore M; Pappatà S
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1348-59. PubMed ID: 26816193
[TBL] [Abstract][Full Text] [Related]
34. Hypermetabolism in 18F-FDG PET predicts favorable outcome following decompressive surgery in patients with degenerative cervical myelopathy.
Floeth FW; Galldiks N; Eicker S; Stoffels G; Herdmann J; Steiger HJ; Antoch G; Rhee S; Langen KJ
J Nucl Med; 2013 Sep; 54(9):1577-83. PubMed ID: 23918736
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
Yoo IeR; Chung SK; Park HL; Choi WH; Kim YK; Lee KY; Wang YP
Biomed Mater Eng; 2014; 24(6):3091-103. PubMed ID: 25227018
[TBL] [Abstract][Full Text] [Related]
36. Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.
Visser EP; Philippens ME; Kienhorst L; Kaanders JH; Corstens FH; de Geus-Oei LF; Oyen WJ
J Nucl Med; 2008 Jun; 49(6):892-8. PubMed ID: 18483085
[TBL] [Abstract][Full Text] [Related]
37. Feasibility of Preoperative FDG PET/CT Total Hepatic Glycolysis in the Remnant Liver for the Prediction of Postoperative Liver Function.
Cho A; Chung YE; Choi JS; Kim KS; Choi GH; Park YN; Kim MJ
AJR Am J Roentgenol; 2017 Mar; 208(3):624-631. PubMed ID: 28026972
[TBL] [Abstract][Full Text] [Related]
38. Reproducibility of (18)F-FDG PET uptake measurements in head and neck squamous cell carcinoma on both PET/CT and PET/MR.
Rasmussen JH; Fischer BM; Aznar MC; Hansen AE; Vogelius IR; Löfgren J; Andersen FL; Loft A; Kjaer A; Højgaard L; Specht L
Br J Radiol; 2015 Apr; 88(1048):20140655. PubMed ID: 25634069
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of 18F-FDG PET in monosegmental stenosis and myelopathy of the cervical spinal cord.
Floeth FW; Stoffels G; Herdmann J; Eicker S; Galldiks N; Rhee S; Steiger HJ; Langen KJ
J Nucl Med; 2011 Sep; 52(9):1385-91. PubMed ID: 21852356
[TBL] [Abstract][Full Text] [Related]
40. Incidental detection of elastofibroma dorsi on PET-CT: initial findings and changes in tumor size and standardized uptake value on serial scans.
Davidson T; Goshen E; Eshed I; Goldstein J; Chikman B; Ben-Haim S
Nucl Med Commun; 2016 Aug; 37(8):837-42. PubMed ID: 27092663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
